Neuren Pharmaceuticals Profile

0.93
USD 0.01  1.09%
60%
0%

Neuren Pharmaceuticals Summary

Neuren Pharmaceuticals Limited (NURPF) is traded on OTC Market in USA. It is located in PWC Tower and employs 10 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 84.73 M. Neuren Pharmaceuticals Limited classifies itself under Healthcare sector and is part of Biotechnology industry. This company has 97.34 M outstanding shares. NEUREN PHARMACEUT has accumulated about 8.43 M in cash with (4.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Neuren Pharmaceuticals Probability Of Bankruptcy

Neuren Pharmaceuticals Target Price Odds Analysis

Odds Below 0.93HorizonTargetOdds Above 0.93
53.97%30 days 0.93 45.86%
Based on normal probability distribution, the odds of Neuren Pharmaceuticals to move above current price in 30 days from now is about 45.86% (This Neuren Pharmaceuticals Limited probability density function shows the probability of Neuren Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Neuren Pharmaceuticals Risk Profiles

Neuren Pharmaceuticals Key Fundamentals

Neuren Pharmaceuticals Against Markets

Neuren Pharmaceuticals Current Ratings

Neuren Pharmaceuticals Limited 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
1 
Chance of
Financial Distress (0 to 100%)
94 
Equity ratings for Neuren Pharmaceuticals Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Neuren Pharmaceuticals Limited, a biopharmaceutical company, engages in the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Auckland, New Zealand. Neuren Pharmaceuticals is traded on OTC Market in USA. more
NameNeuren Pharmaceuticals Limited
CEO, Managing DirectorLarry GlassView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressPWC Tower
ExchangeOTC Market
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.neurenpharma.com
Phone61 3 9092 0480
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017

Neuren Pharmaceuticals Directors

Neuren Pharmaceuticals Corporate Directors

Bruce Hancox Independent Non-Executive Director
Jenny Harry Non-Executive Independent Director
Patrick Davies Non-Executive Independent Director
Please see also Stocks Correlation. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Search macroaxis.com